Skip to main content
SpringerLink
Log in

Comment reconnaître et diagnostiquer la PSP en gériatrie ?

How to diagnose PSP in the elderly?

  • Article Original / Original Article
  • Published:
Les cahiers de l'année gérontologique

Résumé

La paralysie supranucléaire progressive (PSP) est une maladie neurodégénérative dont le diagnostic est clinicopathologique. La forme clinique classique associe la triade : syndrome moteur, syndrome oculomoteur et détérioration intellectuelle. Le diagnostic de PSP peut aussi être évoqué devant un syndrome parkinsonien akinétorigide asymétrique, un syndrome corticobasal, des enrayages cinétiques isolées, un syndrome frontal isolé et une aphasie non fluente progressive. Le traitement est purement symptomatique.

Abstract

Progressive supranuclear palsy is a neurodegenerative disease, formally diagnosed on the basis of clinicopathological analysis. The classical clinical form associates motor, oculomotor and cognitive impairments. However, PSP is clinically heterogeneous and patients may present with an isolated asymmetrical parkinsonian syndrome, a cortico-basal syndrome, freezing, isolated frontal syndrome or non-fluent aphasia with speech apraxia. Current treatment is purely symptomatic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Hauw JJ, Daniel SE, Dickson D, et al (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019

    Article  PubMed  CAS  Google Scholar 

  2. Jellinger KA, Bancher C, Hauw JJ, Verny M (1995) Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 59:106

    Article  PubMed  CAS  Google Scholar 

  3. Verny M, Jellinger KA, Hauw JJ, et al (1996) Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol 91:427–431

    Article  PubMed  CAS  Google Scholar 

  4. Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279

    Article  PubMed  Google Scholar 

  5. Vidailhet M, Rivaud S, Gouider-Khouja N, et al (1994) Eye movements in parkinsonian syndromes. Ann Neurol 35:420–426

    Article  PubMed  CAS  Google Scholar 

  6. Pierrot-Deseilligny C, Rivaud S, Pillon B, et al (1989) Lateral visually-guided saccades in progressive supranuclear palsy. Brain 112:471–487

    Article  PubMed  Google Scholar 

  7. Garbutt S, Matlin A, Hellmuth J, et al (2008) Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer’s disease. Brain 131:1268–1281

    Article  PubMed  Google Scholar 

  8. Pillon B, Dubois B, Lhermitte F, Agid Y (1986) Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson’s disease, and Alzheimer’s disease. Neurology 36:1179–1185

    Article  PubMed  CAS  Google Scholar 

  9. Pillon B, Dubois B, Ploska A, Agid Y (1991) Severity and specificity of cognitive impairment in Alzheimer’s, Huntington’s, and Parkinson’s diseases and progressive supranuclear palsy. Neurology 41:634–643

    Article  PubMed  CAS  Google Scholar 

  10. Pillon B, Deweer B, Michon A, et al (1994) Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer’s, Parkinson’s, and Huntington’s diseases. Neurology 44:1264–1270

    Article  PubMed  CAS  Google Scholar 

  11. Pillon B, Blin J, Vidailhet M, et al (1995) The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology 45:1477–1483

    Article  PubMed  CAS  Google Scholar 

  12. Robbins TW, James M, Owen AM, et al (1994) Cognitive deficits in progressive supranuclear palsy, Parkinson’s disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 57:79–88

    Article  PubMed  CAS  Google Scholar 

  13. Litvan I, Mega MS, Cummings JL, Fairbanks L (1996) Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 47:1184–1189

    Article  PubMed  CAS  Google Scholar 

  14. Aarsland D, Litvan I, Larsen JP (2001) Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 13:42–49

    Article  PubMed  CAS  Google Scholar 

  15. Van der Linden M, Coyette F, Poitrenaud J, et al (2004) L’épreuve du rappel libre/ rapple indicé à 16 items (RL/RL-16). In: L’évaluation des troubles de la mémoire: présentation de quatre tests de mémoire épisodique (avec étalonnage). M Van der Linden, S Adam, A Agniel, et al eds. Marseille Solal pp 25–48

  16. Lhermitte F, Pillon B, Serdaru M (1986) Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients. Ann Neurol 19:326–334

    Article  PubMed  CAS  Google Scholar 

  17. Ghika J, Tennis M, Growdon J, et al (1995) Environment-driven responses in progressive supranuclear palsy. J Neurol Sci 130:104–111

    Article  PubMed  CAS  Google Scholar 

  18. Cambier J, Masson M, Viader F, et al (1985) Frontal syndrome of progressive supranuclear palsy. Rev Neurol 141:528–536

    PubMed  CAS  Google Scholar 

  19. Dubois B, Slachevsky A, Pillon B, et al (2005) Applause sign” helps to discriminate PSP from FTD and PD. Neurology 64:2132–2133

    Article  PubMed  CAS  Google Scholar 

  20. Albert ML, Feldman RG, Willis AL (1974) The “subcortical dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37:121–130

    Article  PubMed  CAS  Google Scholar 

  21. D’Antona R, Baron JC, Samson Y, et al (1985) Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain 108:785–799

    Article  PubMed  Google Scholar 

  22. Foster NL, Gilman S, Berent S, et al (1988) Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 24:399–406

    Article  PubMed  CAS  Google Scholar 

  23. Klein RC, de Jong BM, de Vries JJ, Leenders KL (2005) Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson’s disease. Mov Disord 20:1021–1030

    Article  PubMed  Google Scholar 

  24. Alexander GE, Delong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 9:357–381

    Article  PubMed  CAS  Google Scholar 

  25. Bigio EH, Brown DF, White CL 3rd (1999) Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol 58:359–364

    Article  PubMed  CAS  Google Scholar 

  26. Hauw JJ, Verny M, Delaère P, et al (1990) Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer’s disease and aging. Neurosci Lett 119:182–186

    Article  PubMed  CAS  Google Scholar 

  27. Verny M, Duyckaerts C, Agid Y, Hauw JJ (1996) The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 119:1123–1136

    Article  PubMed  Google Scholar 

  28. Nath U, Ben-Shlomo Y, Thomson RG, et al (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124:1438–1449

    Article  PubMed  CAS  Google Scholar 

  29. Litvan I, Agid Y, Calne D, et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9

    Article  PubMed  CAS  Google Scholar 

  30. Osaki Y, Ben-Shlomo Y, Lees AJ, et al (2004) Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 19:181–189

    Article  PubMed  Google Scholar 

  31. Williams DR, de Silva R, Paviour DC, et al (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 128:1247–1258

    Article  PubMed  Google Scholar 

  32. Williams DR, Lees AJ (2010) What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsyparkinsonism (PSP-P)? Mov Disord 25:357–362

    Article  PubMed  Google Scholar 

  33. O’sullivan SS, Massey LA, Williams DR, et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362–1372

    Article  PubMed  Google Scholar 

  34. Riley DE, Fogt N, Leigh RJ (1994) The syndrome of ‘pure akinesia’ and its relationship to progressive supranuclear palsy. Neurology 44:1025–1029

    Article  PubMed  CAS  Google Scholar 

  35. Compta Y, Valldeoriola F, Tolosa E, et al (2007) Long lasting pure freezing of gait preceding progressive supranuclear palsy: a clinicopathological study. Mov Disord 22:1954–1958

    Article  PubMed  Google Scholar 

  36. Williams DR, Holton JL, Strand K, et al (2007) Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 22:2235–2241

    Article  PubMed  Google Scholar 

  37. Tsuboi Y, Josephs KA, Boeve BF, et al (2005) Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 20:982–988

    Article  PubMed  Google Scholar 

  38. Josephs KA, Petersen RC, Knopman DS, et al (2006) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66:41–48

    Article  PubMed  CAS  Google Scholar 

  39. Boeve BF, Maraganore DM, Parisi JE, et al (1999) Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53:795–800

    Article  PubMed  CAS  Google Scholar 

  40. Cordato NJ, Halliday GM, McCann H, et al (2001) Corticobasal syndrome with tau pathology. Mov Disord 16:656–667

    Article  PubMed  CAS  Google Scholar 

  41. Lang AE (2003) Corticobasal degeneration: selected developments. Mov Disord 18Suppl 6: S51–S56

    Article  PubMed  Google Scholar 

  42. Wakabayashi K, Takahashi H (2004) Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 24:79–86

    Article  PubMed  Google Scholar 

  43. Kertesz A (2005) Frontotemporal dementia: one disease, or many: probably one, possibly two. Alzheimer Dis Assoc Disord 19Suppl 1:S19–S24

    Article  PubMed  Google Scholar 

  44. Josephs KA, Duffy JR (2008) Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 21: 688–692

    Article  PubMed  Google Scholar 

  45. Lladó A, Sánchez-Valle R, Rey MJ, et al (2008) Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration. J Neurol 255:488–494

    Article  PubMed  Google Scholar 

  46. Ogar J, Slama H, Dronkers N, et al (2005) Apraxia of speech: an overview. Neurocase 11:427–432

    Article  PubMed  Google Scholar 

  47. Josephs KA, Duffy JR, Strand EA, et al (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129:1385–1398

    Article  PubMed  Google Scholar 

  48. Deramecourt V, Lebert F, Debachy B, et al (2010) Prediction of pathology in primary progressive language and speech disorders. Neurology 74:42–49

    Article  PubMed  CAS  Google Scholar 

  49. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources Inc

  50. Schrag A, Good CD, Miszkiel K, et al (2000) Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 54:697–702

    Article  PubMed  CAS  Google Scholar 

  51. Oba H, Yagishita A, Terada H, et al (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050–2055

    Article  PubMed  CAS  Google Scholar 

  52. Paviour DC, Price SL, Stevens JM, et al (2005) Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 64:675–679

    Article  PubMed  CAS  Google Scholar 

  53. Bian H, Van Swieten JC, Leight S, et al (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70:1827–1835

    Article  PubMed  CAS  Google Scholar 

  54. Urakami K, Wada K, Arai H, et al (2001) Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J Neurol Sci 183:95–98

    Article  PubMed  CAS  Google Scholar 

  55. Borroni B, Malinverno M, Gardoni F, et al (2008) Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology 71:1796–1803

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de neurologie, Hôpital Saint-Antoine, Assistance publique-hôpitaux de Paris, 184, rue du Faubourg Saint-Antoine, F-75571, Paris cedex 12, France

    R. Levy

Authors
  1. R. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Levy.

About this article

Cite this article

Levy, R. Comment reconnaître et diagnostiquer la PSP en gériatrie ?. cah. année gerontol. 4, 56–62 (2012). https://doi.org/10.1007/s12612-012-0260-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12612-012-0260-3

Mots clés

Keywords

Search

Navigation